ETF Managers Group’s AstraZeneca AZN Stock Holding History

ETF Managers Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$147K	Buy	+1,060	New	+$143K	﹤0.01%	610
2022 Q4	–	Sell	-1,428	Closed	-$157K	–	533
2022 Q3	$157K	Buy	1,428 +77	+6%	+$9.77K	0.01%	625
2022 Q2	$181K	Sell	1,351 -608	-31%	-$79.8K	0.01%	653
2022 Q1	$263K	Sell	1,959 -1,506	-43%	-$181K	0.01%	565
2021 Q4	$405K	Sell	3,465 -753	-18%	-$88.6K	0.01%	549
2021 Q3	$503K	Buy	4,218 +1,018	+32%	+$119K	0.01%	533
2021 Q2	$385K	Sell	3,200 -636	-17%	-$69.8K	0.01%	567
2021 Q1	$383K	Buy	3,836 +284	+8%	+$28.6K	0.01%	544
2020 Q4	$356K	Buy	3,552 +284	+9%	+$30.1K	0.01%	506
2020 Q3	$360K	Buy	3,268 +1,970	+152%	+$219K	0.01%	386
2020 Q2	$137K	Buy	+1,298	New	+$134K	﹤0.01%	571

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ETF Managers Group's AZN Position: Q1 2023 in Review

ETF Managers Group opened a new position in AstraZeneca (AZN) in Q1 2023: 1,060 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #610 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in AZN as recently as Q3 2022.

ETF Managers Group first reported a position in AZN in Q2 2020 and has held it in 11 quarters since. The position peaked at $503K in Q3 2021. 1,054 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

ETF Managers Group held 1,060 shares of AstraZeneca worth $147K as of Q1 2023.
AstraZeneca was a new ETF Managers Group position in Q1 2023.
AstraZeneca made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #610 holding.
ETF Managers Group first reported a position in AstraZeneca in Q2 2020 and has held it in 11 quarters since.
ETF Managers Group's AstraZeneca position peaked at $503K in Q3 2021.
1,054 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.